Anti-inflammatory agents for depression, diabetes and their comorbidity Anti-inflammatory agents for depression and diabetes comorbidity have been explored extensively due to inflammations role in both conditions
Recombinant human HGF, TGF-1 and TGF-2 were from R&D Systems (Minneapolis, MN)
In some aspects, the invention provides methods of treating dementia patients at various stages of dementia, and/or of slowing and/or preventing the progression of dementia to later stages of dementia, or even or reversing the "staging" from advanced to moderate or early, or from moderate to early, stage
It also reduced the number of TGIF-positive neuronal cells, decreased the infarction volume, increased local blood flow, and ultimately improved functional outcomes in rats with TBI